Form: NT 10-Q

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

August 17, 2026

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 12b-25

 

 

NOTIFICATION OF LATE FILING

 

(Check One):   

☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q

☐ Form 10-D  ☐ Form N-CEN  ☐ Form N-CSR

  For Period Ended: June 30, 2026
  ☐ Transition Report on Form 10-K
  ☐ Transition Report on Form 20-F
  ☐ Transition Report on Form 11-K
  ☐ Transition Report on Form 10-Q
  For the transition period ended:  

 

 

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

   

 

PART I — REGISTRANT INFORMATION

INFLEQTION, INC.

Full Name of Registrant

N/A

Former Name if Applicable

1315 West Century Drive, Suite 150

Address of Principal Executive Office (Street and Number)

Louisville, CO 80027

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule12b-25(b), the following should be completed. (Check box if appropriate)

 

☒     (a)   The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
  (b)   The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
  (c)   The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Infleqtion, Inc. (the “Company”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended June 30, 2026 (the “Q2 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) within the prescribed time period due to the ongoing review of certain revenue recognition matters. The Company requires additional time to complete its evaluation of these matters and finalize the related financial statements and disclosures.

In particular, during the preparation of the financial statements for the quarter ended June 30, 2026, the Company identified an error related to revenue recognition and GAAP accounting methodology for the provision of expected losses for certain projects that required adjustments to its previously issued financial statements for the fiscal years ended December 31, 2024 and December 31, 2025 (and the interim periods therein) and the fiscal quarter ended March 31, 2026. The Company determined that the adjustments were not material to the previously issued financial statements for the affected periods. The revenue-recognition adjustments primarily affect the timing of revenue recognition. These adjustments are expected to increase revenue recognized in the year ending December 31, 2026, as a portion of revenue previously reported for the years ended December 31, 2024 and December 31, 2025 will instead be recognized in 2026, with a corresponding reduction in previously reported revenue for those prior years. As a result, the Company will revise the financial information for the affected periods in the Q2 Form 10-Q.

This error relates to the previously disclosed material weakness in the Company’s internal control over financial reporting resulting from the Company’s lack of sufficient accounting personnel to perform effective risk assessment and maintain effective internal controls over the review of accounting transactions.

The Company is working diligently to complete this evaluation and currently expects to file the Q2 Form 10-Q on the date hereof, which is within the five-calendar-day extension period provided under Rule 12b-25.

PART IV — OTHER INFORMATION

 

(1)     Name and telephone number of person to contact in regard to this notification.
    Ilan Hart     303     440-1284
    (Name)     (Area Code)     (Telephone Number)
(2)     Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
   
(3)     Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes ☐ No
    If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 
 


On August 12, 2026, the Company issued a press release announcing preliminary, unaudited financial results for the quarter ended June 30, 2026 and comparing them to the Company’s results for the corresponding period of the last fiscal year (the “Press Release”), which Press Release was furnished as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 12, 2026. The Company is updating those preliminary, unaudited financial results in this Notification of Late Filing on Form 12b-25 (this “Form 12b-25”).

Since the issuance of the Press Release, the Company has identified certain non-cash adjustments to its preliminary results for the second quarter of 2026 related to its recognition of revenue and cost of revenue from certain contracts and, due to the error described in Part III above, certain non-cash adjustments to previously issued financial statements that the Company intends to reflect by revising the affected prior-period financial information in the Q2 Form 10-Q.

As a result, the Condensed Consolidated Balance Sheet as of June 30, 2026 and Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2026 and June 30, 2025 included in the Q2 Form 10-Q will include the adjustments set forth in the tables below, as compared to the financial information included in the Press Release.

 

Condensed Consolidated Balance Sheets  
     As of June 30, 2026  
     Earnings
release
    Adjustments     As
Adjusted
 

ASSETS

      

CURRENT ASSETS:

      

Unbilled receivables

   $ 4,147     $ (669   $ 3,478  

Total current assets

   $ 501,018     $ (669   $ 500,349  

TOTAL ASSETS

   $ 642,123     $ (669   $ 641,454  
  

 

 

   

 

 

   

 

 

 

LIABILITIES, CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

      

CURRENT LIABILITIES:

      

Accrued liabilities

   $ 45,964     $ 342     $ 46,306  

Contract liabilities

   $ 2,511     $ 77     $ 2,588  

Total current liabilities

   $ 53,127     $ 419     $ 53,546  

TOTAL LIABILITIES

   $ 66,652     $ 419     $ 67,071  
  

 

 

   

 

 

   

 

 

 

Stockholders’ Equity:

      

Accumulated deficit

   $ (286,822   $ (1,088   $ (287,910

Total Stockholders’ Equity

   $ 575,471     $ (1,088   $ 574,383  
  

 

 

   

 

 

   

 

 

 

Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit)

   $ 642,123     $ (669   $ 641,454  
  

 

 

   

 

 

   

 

 

 

 

2


Condensed Consolidated Statements of Operations and Comprehensive Loss  
     Three Months Ended June 30, 2026  
     Earnings
release
    Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 2,457       716     $ 3,173  

Service revenue

     10,176       189       10,365  
  

 

 

   

 

 

   

 

 

 

Total revenue

     12,633       905       13,538  
  

 

 

   

 

 

   

 

 

 

Cost of revenue

      

Cost of products

     3,049       (93     2,956  

Cost of services

     8,195       220       8,415  
  

 

 

   

 

 

   

 

 

 

Total cost of revenue

     11,244       127       11,371  
  

 

 

   

 

 

   

 

 

 

Gross profit

     1,389       778       2,167  
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (30,636     778       (29,858
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (25,473     778       (24,695
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (25,473   $ 778     $ (24,695
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (25,809   $ 778     $ (25,031
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.12   $ 0.00     $ (0.11

Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted

     219,743,810       219,743,810       219,743,810  

 

Condensed Consolidated Statements of Operations and Comprehensive Loss  
     Six Months Ended June 30, 2026  
     Earnings
release
    Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 5,607       1,162     $ 6,769  

Service revenue

     16,487       189       16,676  
  

 

 

   

 

 

   

 

 

 

Total revenue

     22,094       1,351       23,445  
  

 

 

   

 

 

   

 

 

 

Cost of revenue

      

Cost of products

     5,879       (191     5,688  

Cost of services

     12,835       220       13,055  
  

 

 

   

 

 

   

 

 

 

Total cost of revenue

     18,714       29       18,743  
  

 

 

   

 

 

   

 

 

 

Gross profit

     3,380       1,322       4,702  
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (64,211     1,322       (62,889
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (55,736     1,322       (54,414
  

 

 

   

 

 

   

 

 

 

Income tax expense (benefit)

     —          —   

Net loss

   $ (55,736   $ 1,322     $ (54,414
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (57,053   $ 1,322     $ (55,731
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.33   $ 0.01     $ (0.32

Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted

     169,199,551       169,199,551       169,199,551  

 

3


Condensed Consolidated Statements of Operations and Comprehensive Loss  
     Three Months Ended June 30, 2025  
     Earnings
release
    Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 4,121       (560   $ 3,561  

Total revenue

     5,837       (560     5,277  
  

 

 

   

 

 

   

 

 

 

Cost of revenue

      

Cost of products

     4,047       (221     3,826  

Total cost of revenue

     4,820       (221     4,599  
  

 

 

   

 

 

   

 

 

 

Gross profit

     1,017       (339     678  
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (10,073     (339     (10,412
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (8,847     (339     (9,186
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (8,847   $ (339   $ (9,186
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (8,869   $ (339   $ (9,208
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.57   $ (0.02   $ (0.59

Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted

     15,586,999       15,586,999       15,586,999  

 

Condensed Consolidated Statements of Operations and Comprehensive Loss  
     Six Months Ended June 30, 2025  
     Earnings
release
    Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 10,521       (668     9,853  

Total revenue

     14,140       (668     13,472  
  

 

 

   

 

 

   

 

 

 

Cost of revenue

      

Cost of products

     8,248       (495     7,753  

Total cost of revenue

     9,746       (495     9,251  
  

 

 

   

 

 

   

 

 

 

Gross profit

     4,394       (173     4,221  
  

 

 

   

 

 

   

 

 

 

Loss from operations

     (17,023     (173     (17,196
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (14,832     (173     (15,005
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (14,832   $ (173   $ (15,005
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (14,438   $ (173   $ (14,611
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.98   $ (0.01   $ (0.99

Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted

     15,164,809       15,164,809       15,164,809  

Also, among the revisions described in Part III above that will be reflected in the Q2 Form 10-Q are the adjustments to the Company’s Consolidated Balance Sheets as of December 31, 2025, the Company’s Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2026 and the Company’s Consolidated Statements of Operations and Comprehensive Loss for the fiscal years ended December 31, 2024 and December 31, 2025 set forth in the tables below.

 

Condensed Consolidated Statements of Operations and Comprehensive Loss  
     Three Months Ended March 31, 2026  
     As Reported     Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 3,150     $ 446     $ 3,596  
  

 

 

   

 

 

   

 

 

 

Total revenue

   $ 9,461     $ 446     $ 9,907  
  

 

 

   

 

 

   

 

 

 

Cost of revenue:

      

Cost of products

   $ 2,830     $ (98   $ 2,732  
  

 

 

   

 

 

   

 

 

 

Total cost of revenue

   $ 7,470     $ (98   $ 7,372  
  

 

 

   

 

 

   

 

 

 

Gross profit

   $ 1,991     $ 544     $ 2,535  
  

 

 

   

 

 

   

 

 

 

Loss from operations

   $ (33,575   $ 544     $ (33,031
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

   $ (30,263   $ 544     $ (29,719
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (30,263   $ 544     $ (29,719
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (31,244   $ 544     $ (30,700
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.26   $ 0.01     $ (0.25

Weighted average shares used in computing net loss per share attributable to common stockholders - basic and diluted

   $ 118,162,332     $ 118,162,332     $ 118,162,332  

 

4


Consolidated Balance Sheets  
     As of December 31, 2025  
     As
Reported
    Adjustments     As
Adjusted
 

ASSETS

      

CURRENT ASSETS:

      

Unbilled receivables

   $ 4,734     $ (2,097   $ 2,637  
  

 

 

   

 

 

   

 

 

 

Total current assets

   $ 74,624     $ (2,097   $ 72,527  
  

 

 

   

 

 

   

 

 

 

TOTAL ASSETS

   $ 115,313     $ (2,097   $ 113,216  
  

 

 

   

 

 

   

 

 

 

LIABILITIES, CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

      

CURRENT LIABILITIES:

      

Accrued liabilities

   $ 8,610     $ 313     $ 8,923  
  

 

 

   

 

 

   

 

 

 

Total current liabilities

   $ 22,672     $ 313     $ 22,985  
  

 

 

   

 

 

   

 

 

 

TOTAL LIABILITIES

   $ 26,746     $ 313     $ 27,059  
  

 

 

   

 

 

   

 

 

 

Stockholders’ Equity (Deficit):

      

Accumulated deficit

   $ (231,086   $ (2,410   $ (233,496
  

 

 

   

 

 

   

 

 

 

Total Stockholders’ Equity (Deficit)

   $ (208,247   $ (2,410   $ (210,657
  

 

 

   

 

 

   

 

 

 

Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit)

   $ 115,313     $ (2,097   $ 113,216  
  

 

 

   

 

 

   

 

 

 

 

Consolidated Statements of Operations and Comprehensive Loss  
     For the period ended December 31, 2025  
     As Reported     Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 19,614     $ (1,356   $ 18,258  
  

 

 

   

 

 

   

 

 

 

Total revenue

   $ 32,464     $ (1,356   $ 31,108  
  

 

 

   

 

 

   

 

 

 

Cost of revenue:

      

Cost of products

   $ 13,558     $ (923   $ 12,635  
  

 

 

   

 

 

   

 

 

 

Total cost of revenue

   $ 20,651     $ (923   $ 19,728  
  

 

 

   

 

 

   

 

 

 

Gross profit

   $ 11,813     $ (433   $ 11,380  
  

 

 

   

 

 

   

 

 

 

Loss from operations

   $ (35,286   $ (433   $ (35,719
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

   $ (31,795   $ (433   $ (32,228
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (31,795   $ (433   $ (32,228
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (31,249   $ (433   $ (31,682
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (0.69   $ (0.01   $ (0.70

Weighted average shares used in computing net loss per share attributable to common stockholders - basic and diluted

   $ 46,185,671     $ 46,185,671     $ 46,185,671  

 

5


Consolidated Statements of Operations and Comprehensive Loss  
     For the period ended December 31, 2024  
     As Reported     Adjustments     As Adjusted  

Revenue

      

Product revenue

   $ 22,325     $ (742   $ 21,583  
  

 

 

   

 

 

   

 

 

 

Total revenue

   $ 28,836     $ (742   $ 28,094  
  

 

 

   

 

 

   

 

 

 

Cost of revenue:

      

Cost of products

   $ 17,571     $ 1,236     $ 18,807  
  

 

 

   

 

 

   

 

 

 

Total cost of revenue

   $ 19,772     $ 1,236     $ 21,008  
  

 

 

   

 

 

   

 

 

 

Gross profit

   $ 9,064     $ (1,978   $ 7,086  
  

 

 

   

 

 

   

 

 

 

Loss from operations

   $ (53,008   $ (1,978   $ (54,986
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

   $ (53,766   $ (1,978   $ (55,744
  

 

 

   

 

 

   

 

 

 

Net loss

   $ (53,764   $ (1,978   $ (55,742
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

   $ (53,290   $ (1,978   $ (55,268
  

 

 

   

 

 

   

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

   $ (1.35   $ (0.05   $ (1.40

Weighted average shares used in computing net loss per share attributable to common stockholders - basic and diluted

   $ 39,808,027     $ 39,808,027     $ 39,808,027  

 

6


Infleqtion, Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 17, 2026     By:  

/S/ Ilan Hart

      Name: Ilan Hart
      Title: Chief Financial Officer

 

7